Inogen Names Scott Wilkinson President, CEO, Effective March 1; Backs FY Outlook

(RTTNews) - Inogen, Inc. (INGN), a medical technology company, announced Tuesday that its Board of Directors has appointed Scott Wilkinson as its President and Chief Executive Officer, effective March 1, 2017.

Wilkinson will also join the Board of Directors on January 1. He will succeed Raymond Huggenberger, who is retiring as Chief Executive Officer, effective March 1. Huggenberger will continue to serve on Inogen's Board following his retirement.

Wilkinson currently oversees Inogen's global commercial, manufacturing, service, research and development, technical and support operations.

Inogen also announced that Scott Beardsley, Sr. Partner, Novo Ventures (US) Inc., has been appointed to Inogen's Board, effective January 1.

In connection with the appointments of Wilkinson and Beardsley, the Board will expand from six to eight members, effective January 1.

Additionally, Inogen announced that Byron Myers, Founder and VP, Marketing will be promoted to EVP, Sales & Marketing, effective January 1.

Further, the company said it has reiterated its fiscal 2016 revenue guidance range of $194 to $198 million, which represents year-over-year growth of 22.0% to 24.5%.

Inogen reiterated its 2016 net income estimate range of $12.5 to $14.5 million, representing 7.9% to 25.2% growth over 2015. Adjusted net income is expected to be in the range of $12.5 to $14.5 million, representing 24.8% to 44.8% growth over 2015.

The company continues to expect adjusted EBITDA of $37.5 to $39.5 million, representing an increase of 16.1% to 22.3% over 2015.